Literature DB >> 33733660

Effect of remote ischaemic preconditioning on mortality and morbidity after non-cardiac surgery: meta-analysis.

K L Wahlstrøm1, E Bjerrum1, I Gögenur1, J Burcharth1, S Ekeloef1.   

Abstract

BACKGROUND: Remote ischaemic preconditioning (RIPC) has been shown to have a protective role on vital organs exposed to reperfusion injury. The aim of this systematic review was to evaluate the effects of non-invasive RIPC on clinical and biochemical outcomes in patients undergoing non-cardiac surgery.
METHODS: A systematic literature search of PubMed, EMBASE, Scopus, and Cochrane databases was carried out in February 2020. RCTs investigating the effect of non-invasive RIPC in adults undergoing non-cardiac surgery were included. Meta-analyses and trial sequential analyses (TSAs) were performed on cardiovascular events, acute kidney injury, and short- and long-term mortality.
RESULTS: Some 43 RCTs including 3660 patients were included. The surgical areas comprised orthopaedic, vascular, abdominal, pulmonary, neurological, and urological surgery. Meta-analysis showed RIPC to be associated with fewer cardiovascular events in non-cardiac surgery (13 trials, 1968 patients, 421 events; odds ratio (OR) 0.68, 95 per cent c.i. 0.47 to 0.96; P = 0.03). Meta-analyses of the effect of RIPC on acute kidney injury (12 trials, 1208 patients, 211 events; OR 1.14, 0.78 to 1.69; P = 0.50; I2 = 9 per cent), short-term mortality (7 trials, 1239 patients, 65 events; OR 0.65, 0.37 to 1.12; P = 0.12; I2 = 0 per cent), and long-term mortality (4 trials, 1167 patients, 9 events; OR 0.67, 0.18 to 2.55; P = 0.56; I2 = 0 per cent) showed no significant differences for RIPC compared with standard perioperative care in non-cardiac surgery. However, TSAs showed that the required information sizes have not yet been reached.
CONCLUSION: Application of RIPC to non-cardiac surgery might reduce cardiovascular events, but not acute kidney injury or all-cause mortality, but currently available data are inadequate to confirm or reject an assumed intervention effect.
© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33733660      PMCID: PMC7970092          DOI: 10.1093/bjsopen/zraa026

Source DB:  PubMed          Journal:  BJS Open        ISSN: 2474-9842


  93 in total

1.  Remote Ischaemic Preconditioning Attenuates Cardiac Biomarkers During Vascular Surgery: A Randomised Clinical Trial.

Authors:  Teele Kepler; Karl Kuusik; Urmas Lepner; Joel Starkopf; Mihkel Zilmer; Jaan Eha; Mare Vähi; Jaak Kals
Journal:  Eur J Vasc Endovasc Surg       Date:  2019-12-20       Impact factor: 7.069

Review 2.  2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).

Authors:  Steen Dalby Kristensen; Juhani Knuuti; Antti Saraste; Stefan Anker; Hans Erik Bøtker; Stefan De Hert; Ian Ford; Jose Ramón Gonzalez Juanatey; Bulent Gorenek; Guy Robert Heyndrickx; Andreas Hoeft; Kurt Huber; Bernard Iung; Keld Per Kjeldsen; Dan Longrois; Thomas F Luescher; Luc Pierard; Stuart Pocock; Susanna Price; Marco Roffi; Per Anton Sirnes; Miguel Sousa Uva; Vasilis Voudris; Christian Funck-Brentano
Journal:  Eur J Anaesthesiol       Date:  2014-10       Impact factor: 4.330

3.  Effect of remote ischaemic preconditioning in patients with ischaemic heart disease undergoing orthopaedic surgery: a randomized controlled trial.

Authors:  S-K Park; M Hur; S Yoo; J-Y Choi; W H Kim; J-T Kim; J-H Bahk
Journal:  Br J Anaesth       Date:  2017-11-23       Impact factor: 9.166

4.  Effects of Ischemic Preconditioning on Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis.

Authors:  Simon De Freitas; Caitlin W Hicks; Ronelle Mouton; Santiago Garcia; Donagh Healy; Caoilfhionn Connolly; Kate N Thomas; Stewart R Walsh
Journal:  J Surg Res       Date:  2018-11-13       Impact factor: 2.192

5.  Endothelial dysfunction in the early postoperative period after major colon cancer surgery.

Authors:  S Ekeloef; M H H Larsen; A M V Schou-Pedersen; J Lykkesfeldt; J Rosenberg; I Gögenür
Journal:  Br J Anaesth       Date:  2017-02       Impact factor: 9.166

6.  Remote ischemic preconditioning does not affect the incidence of acute kidney injury after elective abdominal aortic aneurysm repair.

Authors:  Noelle Murphy; Ajith Vijayan; Stephen Frohlich; Frank O'Farrell; Mary Barry; Stephen Sheehan; John Boylan; Niamh Conlon
Journal:  J Cardiothorac Vasc Anesth       Date:  2014-10       Impact factor: 2.628

7.  The remote ischemic preconditioning algorithm: effect of number of cycles, cycle duration and effector organ mass on efficacy of protection.

Authors:  Jacob Johnsen; Kasper Pryds; Rasha Salman; Bo Løfgren; Steen Buus Kristiansen; Hans Erik Bøtker
Journal:  Basic Res Cardiol       Date:  2016-01-14       Impact factor: 17.165

8.  Remote ischemic preconditioning improves the cognitive function of elderly patients following colon surgery: A randomized clinical trial.

Authors:  Zhenqiu He; Nan Xu; Sihua Qi
Journal:  Medicine (Baltimore)       Date:  2017-04       Impact factor: 1.889

9.  Effect of Remote Ischaemic Preconditioning on Liver Injury in Patients Undergoing Major Hepatectomy for Colorectal Liver Metastasis: A Pilot Randomised Controlled Feasibility Trial.

Authors:  Sanjeev Kanoria; Francis P Robertson; Naimish N Mehta; Giuseppe Fusai; Dinesh Sharma; Brian R Davidson
Journal:  World J Surg       Date:  2017-05       Impact factor: 3.352

10.  Effect of Combined Treatment of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-Reperfusion Injury in Patients Undergoing Partial Nephrectomy: Pilot Study.

Authors:  Hae Keum Kil; Ji Young Kim; Young Deuk Choi; Hye Sun Lee; Tae Kwang Kim; Ji Eun Kim
Journal:  J Clin Med       Date:  2018-11-23       Impact factor: 4.241

View more
  1 in total

Review 1.  Analysis of Risk Factors for Perioperative Acute Kidney Injury and Management Strategies.

Authors:  Xiang Yu; Zhe Feng
Journal:  Front Med (Lausanne)       Date:  2021-12-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.